Xypat Eye Drop contains Olopatadine 0.2% w/v, a selective histamine H1 receptor antagonist with potent anti-allergic properties. It is indicated for the treatment of allergic conjunctivitis, providing rapid relief from symptoms such as itching, redness, and swelling of the eyes caused by allergens. Olopatadine works by inhibiting the release of histamine and other inflammatory mediators from mast cells, thereby reducing the allergic response. Xypat Eye Drop is administered topically, typically one drop in the affected eye(s) twice daily or as directed by a healthcare professional. The formulation is designed to ensure optimal ocular bioavailability and patient comfort. It is well-tolerated, with minimal systemic absorption, and adverse effects are generally mild and transient, including temporary burning or stinging upon instillation. Xypat Eye Drop should be used with caution in patients with hypersensitivity to any component of the formulation. It is contraindicated in cases of ocular infections or injuries unless advised by a physician. Patients are advised to avoid contact lenses during treatment or to remove lenses prior to application and wait at least 15 minutes before reinsertion. Xypat Eye Drop offers an effective therapeutic option for managing allergic eye conditions, improving patient quality of life by alleviating discomfort and inflammation.